Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT |
| |
| Authors: | Michel Komajda,Michael B hm,Jeffrey S Borer,Ian Ford,Michele Robertson,Athanasios J. Manolis,Luigi Tavazzi,Karl Swedberg |
| |
| Affiliation: | 1. Institute of Cardiometabolism and Nutrition (ICAN), Pierre et Marie Curie Paris VI University, La Pitié‐Salpétrière Hospital, Paris, France;2. Universit?tskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany;3. Division of Cardiovascular Medicine and the Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, New York, NY, USA;4. Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK;5. Asklepeion Hospital, Athens, Greece;6. Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy;7. Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, G?teborg, Sweden |
| |
| Abstract: | |
| |
| Keywords: | Blood pressure Ivabradine Outcomes Systolic heart failure SHIFT |
|
|
